Piehl F, Alping P, Virtanen S, Englund S, et al. COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab. Ann Neurol 2024 Jun 25. doi: 10.1002/ana.27012.
PMID: 38923558